Adagene (ADAG) Share-based Compensation (2020 - 2025)

Adagene's (ADAG) quarterly Share-based Compensation came in at $5.2 million in Q4 2025, down 10.27% year-on-year from $5.8 million in Q4 2024, and down 10.27% on a QoQ basis from $5.8 million in Q4 2024.

Adagene (ADAG) Share-based Compensation (2020 - 2025) Analysis & Trends

Adagene (ADAG) has 6 years of Share-based Compensation data on file, last reported at $5.2 million in Q4 2025.

  • On a quarterly basis, Share-based Compensation fell 10.27% year-over-year to $5.2 million in Q4 2025; TTM through Dec 2025 was $5.2 million, a 10.27% decrease from a year earlier, with the FY2025 full-year figure at $5.2 million, down 10.27% from the prior year.
  • Share-based Compensation for Q4 2025 stood at $5.2 million, down from $5.8 million in the prior quarter.
  • Over the last five years, Share-based Compensation for ADAG reached as high as $30.6 million in Q4 2021 and fell as low as $5.2 million in Q4 2025.
  • Historically, Share-based Compensation has averaged $16.4 million across 5 years, with a median of $16.7 million in 2023.
  • Across the five-year window, Share-based Compensation declined 10.23% in 2021 and sank 65.32% in 2024, its largest moves.
  • Year by year, Share-based Compensation stood at $30.6 million in 2021, then decreased by 22.78% to $23.6 million in 2022, then fell by 29.52% to $16.7 million in 2023, then sank by 65.32% to $5.8 million in 2024, then declined by 10.27% to $5.2 million in 2025.
  • Per Business Quant data, the three most recent Share-based Compensation figures were $5.2 million in Q4 2025, $5.8 million in Q4 2024, and $16.7 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 6.39 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9.26 Mn
4 NuCana 279.75 Bn 279.75 Bn - 1.18 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 166.40 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 257.40 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 87.30 Mn
10 Adagene 198.85 Mn 198.85 Mn - 5.18 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 5.18 Mn
Dec 31, 2025 5.18 Mn
Dec 31, 2024 5.78 Mn
Dec 31, 2024 5.78 Mn
Dec 31, 2023 16.66 Mn
Dec 31, 2023 16.66 Mn
Dec 31, 2022 23.64 Mn
Dec 31, 2022 23.64 Mn
Dec 31, 2021 30.61 Mn
Dec 31, 2021 30.61 Mn
Dec 31, 2020 34.10 Mn
Dec 31, 2020 34.10 Mn